NCT07092059 Smartphone Services for Stimulant Use Disorder
| NCT ID | NCT07092059 |
| Status | Recruiting |
| Phase | — |
| Sponsor | DynamiCare Health |
| Condition | Stimulant Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 270 participants |
| Start Date | 2025-06-24 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 270 participants in total. It began in 2025-06-24 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is testing two approaches to treating Stimulant Use Disorder, or problems with cocaine, crack, methamphetamine, etc. Stimulant Use Disorder is a national epidemic in the U.S. but there is no FDA-approved medication to treat it. There is a behavioral approach that has been found to be the most effective treatment for Stimulant Use Disorder, but this study is testing whether this can be delivered by a smartphone service, remotely, such as at home.
Eligibility Criteria
Inclusion Criteria: * Adults who are at least 18 years old, speak/read English, have a smartphone, and who meet criteria for Stimulant Use Disorder, active or early remission. If being discharged to outpatient or intensive outpatient care, the patient is eligible. Exclusion Criteria: * Unwilling to authorize communication with any treatment provider(s), requiring acute detoxification from alcohol or opioids or residential or hospital treatment, or other obstacle to longitudinal participation in the study. * Currently pregnant
Contact & Investigator
Carla J Rash, PhD
PRINCIPAL INVESTIGATOR
UConn Health
Frequently Asked Questions
Who can join the NCT07092059 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stimulant Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07092059 currently recruiting?
Yes, NCT07092059 is actively recruiting participants. Contact the research team at enrollment@dynamicarehealth.com for enrollment information.
Where is the NCT07092059 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07092059 clinical trial?
NCT07092059 is sponsored by DynamiCare Health. The principal investigator is Carla J Rash, PhD at UConn Health. The trial plans to enroll 270 participants.